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a b s t r a c t
Due to migration of harbour porpoises towards more polluted areas like the North Sea and their
sensitivity towards pollution, there is a need for proper conservation measures for this species. As
a consequence, knowledge about the pollutant’s kinetics is required. The present study is the ﬁrst to
investigate the kinetics of PBDEs in marine mammals using PBPK modeling as a non-destructive tool for
describing the chemical’s kinetics in a protected animal species. The models were developed and
parameterized using data from the literature and Black Sea harbour porpoises through computer opti-
mization. The predictability of these models in time was assessed by reverse dosimetry modeling using
data from North Sea porpoises (1990e2008). From these predictions, PBDE 99 levels were found to
decrease the fastest, followed by PBDE 153, 47 and 100. Results show that the PBPK models can be
applied for harbour porpoises from different regions and also simulate time trends.
! 2011 Elsevier Ltd. All rights reserved.
1. Introduction
Polybrominated diphenyl ethers (PBDEs) have been used as
ﬂame retardants in various products and equipment ranging from
textiles to electronics. They have been banned in many countries
(ATSDR, 2004); however, they are still ubiquitous in the environ-
ment due to their stability and persistence (Birnbaum and Staskal,
2004). Some PBDEs have the potential to biomagnify in terrestrial
and aquatic food webs (Kelly et al., 2007; Voorspoels et al., 2007).
Biomagniﬁcation is of particular concern for organisms at the top of
the food chains, such as marine mammals, as they receive high
concentrations of PBDEs from their prey. In addition, lactational
transfer of chemicals through the lipid rich milk (up to 40% fat)
represents also a major source of contaminants for these animals
(Debier et al., 2003; Hickie et al., 2007; Weijs et al., 2009a). Several
PBDEs were shown to be toxic on the reproductive, immune and
endocrine systems of marinemammals (Sonne et al., 2009; Beineke
et al., 2010; Frouin et al., 2010).
Physiologically based pharmacokinetic (PBPK) models represent
a mass-balanced system of compartments where the pollutant’s
distribution is regulated according to the physiological properties of
the compartments or tissues and the biochemistry of the pollutants
(Reddy et al., 2005; Chiu et al., 2007). Recently, PBPK modeling has
been applied for showing the kinetics of speciﬁc environmental
pollutants in marine mammals (Hickie et al., 1999, 2005; Weijs et al.,
2010a). PBPK models for marine mammals are very helpful since
these animals are endangered and protected, so that in vivo exposure
experiments cannot be undertaken. In vitro exposure tests can be
performed in marine mammal derived cell and tissue cultures of
blood and liver (McKinney et al., 2006; Das et al., 2008; Frouin et al.,
2010). However, the samplingof liver biopsies or blood fromthe same
animal of a wild marine mammal species is too invasive. Therefore,
blubber was the most investigated tissue and is still the best known
source of biomonitoring results of lipophilic compounds to date.
PBPKmodels have the potential to integrate in vitro experimental
data in liver or blood with biomonitoring information from blubber,
so that a non-destructive, in silico approach can be developed. With
the help of PBPK models, blubber concentrations can be used to
predict levels in liver, blood and other tissues thus giving more
realistic exposure scenarios than working with hepatic or blood cell
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lines alone. Since blubber samples can be taken in a non-destructive
manner from dead and living marine mammals, the PBPK models
would, in addition to the in vitro tests done with liver cells, allow the
assessment of toxicity in a more rapid and instantaneous way.
Furthermore, PBPKmodels are important to describe the dynamics of
the exposure-accumulation process. This can simulate the impact of
releases of pollutants and remedial measures on their long-term fate
and accumulation in marine mammals.
Harbour porpoises have relatively long life spans and feed at the
top of the aquatic food chains, resulting in high body burdens of
pollutants (Weijs et al., 2009a, 2010a). Previous studies have sug-
gested that harbour porpoises are less able to metabolize several
pollutants compared to harbour seals. They were found to have
higher proportions of PBDEs in their blubber compared to harbour
seals even though both species had a comparable diet (Weijs et al.,
2009a,b). In addition, hydroxylated PBDE metabolites (HO-PBDEs)
could not be detected in serum of harbour porpoises (Weijs et al.,
2009c). During the last decade, movements of harbour porpoises
from northern areas to the more polluted Southern North Sea have
raised concerns about the viability of the population. These move-
ments and their sensitivity to pollution justify the need for proper
conservation measures for these animals.
Similarly to models developed for polychlorinated biphenyls
(PCBs; Weijs et al., 2011), the goals of the current study were 1) to
develop a non-destructive computational toxicology approach to
study protected marine mammals such as harbour porpoises by
formulating PBPKmodels for PBDEs, and 2) to assess temporal trends
of lifetime exposure to PBDEs in North Sea harbour porpoises using
data from 1990 to 2008.
2. Materials and methods
The models developed for PBDEs are based on the PBPK model for the bio-
accumulation of PCB 153 in male harbour porpoises (Weijs et al., 2010a). In general,
PBPK models for females include processes (e.g. lactation, gestation) which are
responsible for the transfer of contaminants to the offspring thereby reducing the
overall concentrations of the chemicals in the females. PBPK models for males lack
these processes, so the models developed in the present study are suitable for males
only. Similar as in Weijs et al. (2010a), all models consisted of 5 compartments, liver,
blubber, kidneys, brain and rest of the body. All tissues were considered to be ﬂow-
limited similar as in Weijs et al. (2010a). Dietary uptake, either through the
consumption of ﬁsh ormilk, was set directly to the liver compartment as the liver was
the only tissue of the gastrointestinal tract used in the models. Models were devel-
oped and parameterized using Berkeley Madonna software version 8.3.14 (Berkeley
Madonna Inc) and model codes are available on request to the corresponding author.
2.1. Parameters
All models were developed using parameters taken from the literature or ﬁtted to
the data if clearly indicated. The same physiological parameters and equations of the
male harbour porpoises (such as the relationships between body size, age and daily
intake) as in Weijs et al. (2010a) were used. Biochemical parameters were adjusted
according to the speciﬁc PBDE congener (Table 1). The parameters that were ﬁtted
(elimination half-lives, assimilation efﬁciency for the milk or AE2 and brain/blood
partition coefﬁcients or PB) were chosen upon visual inspection of the position and
shape of the curves compared to the real-life data from animals from the Black Sea. Of
these three parameters, elimination half-liveswereﬁttedﬁrst as this parameter affects
the slope of the curve in each compartment. AE2 was ﬁtted after that as it determined
only the concentrations in all compartments for animals< 1 year. PBs only had an
impact on the curve of the brain compartment and were therefore ﬁtted last.
Exposure was assumed to be through ﬁsh and milk consumption only which
were both set in the liver as this compartment was the only tissue of the gastro-
intestinal tract represented in the models. Lipophilic compounds like PBDEs do not
dissolve easily in sea water and dermal exposure was earlier found to play only
a negligible role for the bioaccumulation of PCBs in beluga whales (Hickie et al.,
1999). Tanabe et al. (1997) reported on the concentrations of several PCBs, but not
of PBDEs, in the ﬁsh prey of the harbour porpoises from the Black Sea. The lack of
PBDE data in marine mammals and their prey appears to be the norm, especially for
Black Sea porpoises. Thus, we relied on PBPK modeling using the best available data
to determine the validity of the model. An assumption was made that PBDEs share
similar physical and chemical properties (e.g. two phenyl rings with halogenated
atoms, comparable log Kow values for matched congeners) with PCB congeners. This
assumption was applied to estimate the dietary ﬁsh input of PBDEs using the
concentrations of PBDEs in milk samples (n¼ 7) of Black Sea porpoises. In the PCB
153 model, there was a 116 times difference between the concentration in the milk
(127.6 ng/g ww) and the concentration in the ﬁsh (1.1 ng/g ww; Tanabe et al., 1997;
Weijs et al., 2010a). This factor, together with the results of the milk samples
(Supporting Information Table S1), was used to calculate the concentrations in the
ﬁsh prey of the Black Sea porpoises leading to a concentration in ﬁsh of 0.054, 0.008,
0.009 and 0.002 ng/g ww for PBDE 47, 99, 100 and 153, respectively.
Physiological parameters were kept as general as possible by using preferentially
physiological information of harbour porpoises in general and not only from Black
Sea or North Sea harbour porpoises. This was done to make the models species-
speciﬁc rather than population-speciﬁc. As such, the models should allow compar-
isons between harbour porpoises from different areas (e.g. Black Sea and North Sea).
2.2. Datasets
The datasets used include results of PBDEs in tissues of harbour porpoises from
the Black Sea (milk, liver, blubber, kidney, brain and muscle) for goal 1 and blubber
results from the North Sea for goal 2. For goal 1, results of one neonate were also
used (Table 1).
2.2.1. Black Sea dataset
This dataset was used to parameterize the PBDE models (goal 1), similar to the
PCB models in male harbour porpoises (Weijs et al., 2010a, 2011). The dataset
contains results for 8 PBDEs in 20 male harbour porpoises (9 juveniles,11 adults). All
animals were by-caught or found stranded in 1998 in the Black Sea and results of
PBDEs in blubber, liver, kidney, brain and muscle are discussed thoroughly in Weijs
et al. (2010b).
Table 1
Compound speciﬁc parameters for several PBDEs. The original values of the param-
eters are given between brackets for parameters that were ﬁtted to the data.
PBDE 47 PBDE 99 PBDE 100 PBDE 153
Log (Kfp)a 2.35750 2.41682 2.41682 2.35750
PFb 331.6 380.2 380.2 331.6
PLb 7.9 9.0 9.0 7.9
PKb 4.6 5.3 5.3 4.6
PBb 1.6 (13.3) 2.2 (15.2) 8.2 (15.2) 6.3 (13.3)
PRb 8.1 9.2 9.2 8.1
AE1 (%)c 95 98 99 97
AE2 (%)d 40 31 25 25
CFoetusFe 14.1 1.8 2.0 0.3
CFoetusLe 5.5 0.8 1.1 0.7
CFoetusKe 6.3 5.6 0.5 ND
CFoetusBe 1.0 ND 0.2 ND
Half-life (yr) 4.24 (3.1f) 5.17 (2.9g) 4.63 (1.6g) 9.43 (6.5g)
Kfpe adipose tissue/plasma partition coefﬁcient, PFe adipose tissue/blood partition
coefﬁcient, PL e liver/blood partition coefﬁcient, PK e kidney/blood partition
coefﬁcient, PB e brain/blood partition coefﬁcient, PR e muscle/blood partition
coefﬁcient, AE e assimilation efﬁciency.
a Adipose tissue to plasma partition coefﬁcients (Kfp) from Parham et al. (1997)
are actually for PCBs, but are used here for PBDEs as well; e.g. the log (Kfp) for
PBDE 47 is actually for PCB 47. Parham et al. (1997) does not report on PCB 100, so
for PBDE 100 the same value as for PBDE 99 (or PCB 99) was used.
b Equations from Parham et al. (1997) were transformed to equations for bot-
tlenose dolphins (blood composition from Bossart et al., 2001). For partition coef-
ﬁcients of tissues (liver, kidneys, brain) as given in Table 1, the average lipid content
was used (Weijs et al., 2010b). For the ‘rest of the body’-compartment, the average
lipid content of muscle was used (Weijs et al., 2010b).
c Assimilation efﬁciency for the ﬁsh diet or the percentage of PBDE absorbed by
the juveniles and adults after ingestion of the ﬁsh prey. Values taken from Thomas
et al. (2005).
d Assimilation efﬁciency for the milk diet or the percentage of PBDE absorbed by
the calves after milk ingestion. Values were ﬁtted to the Black Sea data.
e Results from own analyses (Weijs, unpublished data) and expressed in ng/g lipid
weight (lw). For modeling reasons, values of 0.01 ng/g lw were used for concentra-
tions below limit of detection (ND). Muscle tissue of the fetus was not available, so
a value of 0.01 ng/g lw was used here for the ‘rest of the body’ compartment as well.
f Staskal et al. (2005) found a terminal half-life of PBDE 47 in mice of 23 days after
a single exposure, which is comparable with the half-life values of TCDD in mice
(Miniero et al., 2001). Therefore, the elimination half-life for PBDE 47 in harbour
porpoises was derived from the half-life of TCDD which is body weight-dependent
(Miniero et al., 2001). The body weight of the harbour porpoises from the Black Sea
in the present study varies from 4.1 to 48.5 kg, resulting in half-life values for TCDD
(and thus PBDE 47) ranging from 330 days to 5.4 years with an average of 3.1 years.
g Geyer et al. (2004) expressed in years.
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2.2.2. North Sea dataset
The blubber data were used to investigate the usefulness of the PBPK models to
predict PBDE accumulation in time (goal 2), as done for PCBs (Weijs et al., 2011). A
part of the animals included in this dataset were found stranded or were by-caught
along the Belgian coast of the North Sea. These animals were from 1999e2004, the
PBDE results in blubber can be found in Weijs et al. (2009a,b). The other part of the
animals from this dataset were found alive on the coasts of Belgium and The
Netherlands, but died during rehabilitation in SOS Dolﬁjn, Harderwijk, The
Netherlands. These animals were sampled between 1990 and 2008 and data of
PBDEs in blubber can be found in Weijs et al. (2010c).
2.3. Sensitivity analysis
To assess the impact of some physiological parameters independent of the body
weight on the model outcome, sensitivity analyses were performed as was done
previously for PCB 153 (Weijs et al., 2010a). For each parameter, 3 runs (a batch run)
were set simultaneously using the original value of the parameter and a coefﬁcient
of variation of 5%, resulting in a run with the original parameter, a run with the
original parameter increased with 5% and a run with the original parameter
decreased with 5%. The impact of the parameter changes on the concentration of
PBDE 47, PBDE 99, PBDE 100 and PBDE 153, respectively, in blood was determined by
calculating sensitivity coefﬁcients (%) according to the following equation (modiﬁed








With AUCOrig the area under the blood concentration curve with the original
parameter value and AUC5 the areas under the blood concentration curves with the
original parameter value increased and decreased with 5%. Blood is the circulation
medium between all tissue compartments (liver, brain, blubber, kidney and rest of the
body), so changes in one or more of these compartments are reﬂected in the blood.
Therefore, the blood concentration curves were used for the sensitivity analyses.
3. Results
3.1. Goal 1: computational toxicology approach: development of
PBPK models for PBDEs
Elimination half-lives of PBDEs, or the time at which 50% of the
chemical is eliminated from the body by metabolic biotransforma-
tion, fecal or urinary excretion, are scarce in the literature. Geyer et al.
(2004) estimated elimination half-lives for several PBDEs in humans
(Table 1) which are higher than PBDE half-lives in rodents (Staskal
et al., 2005). Nevertheless, considering the continuous exposure
and the higher lipid deposits of marine mammals compared to
rodents, the human values were here preferred. However, when the
human PBDE elimination half-lives were incorporated into the PBPK
models, the resulting simulation results were not consistentwith the
tissue concentration dataset from Black Sea harbour porpoises.
Therefore, optimization for suitable elimination half-lives for each
PBDE congenerwas obtained by using the Black Sea dataset (Table 1).
3.1.1. PBDE 47
When the optimized half-life for PBDE 47 of 4.24 years was
incorporated into the PBPK model, the computer simulation results
seemed more appropriate, not only for all compartments, but also
for all ages (Fig. 1AeE). In all compartments, the model reached
a peak in concentrations at the end of lactation followed by a steady
decline until the age of about 3 years. After that, levels of PBDE 47
increased slightly in the males until the end of their lives. Despite
this increase, the calves at the end of the nursing period were
predicted to have the highest concentrations of all ages, as the
concentrations of PBDE 47 never reach the same level again
according to the model predictions (Fig. 1AeE). Typically, concen-
trations of PBDE 47 were highest in the blubber, followed by the
muscles (rest of the body), liver, kidney and brain (Fig. 1AeE).
3.1.2. PBDE 99
According to the model simulations, the half-lives from Geyer
et al. (2004) needed to be almost doubled to provide a better ﬁt
compared to the Black Sea data (Table 1). The resulting curves
reached a peak after the ﬁrst 4 months due to lactational transfer,
followed by a decline until the age of 3 years. The increase after the
age of about 3 years was however steeper compared to the increase
seen in the PBDE 47 model. Consequently, the predicted concentra-
tions of PBDE 99 from the age of 9 years onward were higher than
those in calves at the end of the nursing period (Supporting
Information Fig. S1AeE). This pattern was observed in all compart-
ments with the highest concentrations in blubber, followed by the
muscle (rest of the body), liver, kidney and brain (Supporting
Information Fig. S1AeE).
3.1.3. PBDE 100
Although the individual data from the Black Sea porpoises were
more scattered for PBDE 100 (for example in the liver, Supporting
Information Fig. S2B), there was an increase in concentrations of
PBDE 100 in all compartments. The ﬁnal value for the elimination
half-life of 4.63 years, ﬁtted by the model, was almost three times
higher than the original value of 1.6 years for humans (Geyer et al.,
2004). The model predicted a peak concentration at the end of
lactation, a decrease in concentrations from the end of lactation
until the age of about 3 years and a steep increase after that,
resulting in higher concentrations of PBDE 100 in adults than in
calves (Supporting Information Fig. S2AeE). Again, higher levels of
PBDE 100 were found in blubber, muscle (rest of the body),
liver, kidney and brain, respectively (Supporting Information
Fig. S2AeE).
3.1.4. PBDE 153
The Black Sea animals lacked a general trend for PBDE 153 in the
liver compartment compared to all other tissues (Supporting
Information Fig. S3B), which could not be solved by other values
for the blood/liver partition coefﬁcient because of the high degree
of scattering. In accordance with PBDE 99 and 100, the concentra-
tions in the adult animals after the age of 3 years were higher than
the levels in the calves. The ﬁnal value for the elimination half-life
of 9.43 years, ﬁtted by the model, was 50% greater than the liter-
ature value of 6.5 years (Geyer et al., 2004). As for the other PBDE
congeners, the general proﬁle was conserved also for concentra-
tions of PBDE 153 in all compartments (Supporting Information
Fig. S3AeE).
3.1.5. Sensitivity analysis
Sensitivity coefﬁcients are available inTables S2eS5 in Supporting
Information for themodel of PBDE47, 99,100 and153, respectively. In
all models, the most sensitive parameters are the parameters related
to the blood (e.g. density of blood, fat percentage of blood), followed
by the parameters that are responsible for the intake of ﬁsh
(e.g. concentration in the ﬁsh and assimilation efﬁciency for the ﬁsh
diet), the elimination half-life values and some tissue-related
parameters (e.g. blood/blubber partition coefﬁcient, density of the
liver and density of the blubber. Parameters that are responsible for
the intake of milk have an impact on the bioaccumulation of PBDE 47
(Table S2), but not on PBDE 99, 100 and 153 (Tables S3eS5).
3.2. Goal 2: assessing temporal trends for PBDEs
Using the PBDE results in blubber of North Sea harbour porpoises
from 1990 until 2008 (n¼ 46) (Weijs et al., 2009a, 2010c), changes
over time were investigated. The models used for the time trends
were those described in goal 1, except for the speciﬁc input values for
PBDE concentrations in the ﬁsh and in the milk. Although the input
parameters changed with reverse dosimetry modeling (PBDE 99:
0.42 to 0.10 ng/g; PBDE 100: 0.38 to 0.24 ng/g; PBDE 47: 1.08 to
0.54 ng/g; PBDE 153: 0.43 to 0.17 ng/g) meaning that they were
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adjusted in order to ﬁnd curves that would ﬁt to the North Sea data,
theproportionbetween the concentrations inmilk andﬁsh remained
unchanged (116 times difference) throughout thismodeling exercise.
As inWeijs et al. (2011), the North Sea datawere initially added to the
models per year, but since the input parameterswere very similar for
data from 1990e2001 and from 2002e2008, all data were pooled in
these two groups (Fig. 2AeD). Between the two groups, there were
differenceswith thehighest concentrationsof PBDEs in the olderdata
(1990e2001). Results reveal that, in a period of about 18 years, levels
of PBDE 99 decreased the fastest with 4.2 times lower levels in
2002e2008 than in 1990e2001 (Fig. 2B). Levels of PBDE 100
decreased the slowest with only a 1.6 times difference between
concentrations in 1990e2001 compared to 2002e2008 (Fig. 2C). For
PBDE 47 and 153, there was a difference of 2.0 and a 2.5 times,
respectively, between the levels in 1990e2001 and 2002e2008
(Fig. 2A, D).
4. Discussion
Although PBDEs have been banned in the EU in 2004 and 2008,
their presence and high levels in wildlife can still be toxic. For
decades, risk assessment of pollutants in marine mammals has
mainly been performed through biomonitoring on blubber from
dead animals. Marine mammals are protected species, so these
blubber data are generally the only experimental data available.
Recently, in vitro exposure studies in hepatic or blood cells of marine
mammals have gained more attention (McKinney et al., 2006; Das
et al., 2008; Frouin et al., 2010). Unfortunately, the connection
between reported levels of pollutants in the blubber (from dead or
live animals) and the effects found in liver (from dead animals) or
blood (from live animals) is often blurred or even non-existent. This
can be solved through PBPKmodeling as a non-destructive approach
in marine mammal toxicology. It combines computational
Fig. 1. Age-dependent bioaccumulation of PBDE 47 (expressed in ng/g lw) in (A) blubber, (B) liver, (C) kidney, (D) brain and (E) muscle (rest of the body) of male harbour porpoises
from the Black Sea. ¼ Individual data from male harbour porpoises from the Black Sea from 1998 (Weijs et al., 2010b), ¼model prediction with tissue/blood partition
coefﬁcient calculated with the average lipid content of the respective tissue, ¼model predictions with tissue/blood partition coefﬁcients calculated with the minimum and
maximum lipid percentage of the respective tissue, ¼model prediction with ﬁtted tissue/blood partition coefﬁcient.
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technology, physiology of the organism and biochemistry of the
compound of interest. As such, PBPK modeling is certainly in line
with the spirit of reducing or eliminating animal experimentation by
the REACH (Registration, Evaluation, Authorization, and Restriction
of Chemical substances) legislation in the EU.
4.1. Goal 1: computational toxicology approach: development of
PBPK models for PBDEs
The search for reliable parameters necessary to develop PBPK
models for marine mammals is a challenging task. Typical experi-
mental model organisms, such as rodents, often have a different
physiology from marine mammals and thus the available parame-
ters fromother species are not always suitable formarinemammals.
4.1.1. Elimination half-lives
In PBPK models for PCBs in harbour porpoises, the elimination
half-lives were much higher than those reported in the literature,
probably due to their larger lipid stores of marine mammals
compared to rodents or humans. Because of the size differences
between humans and rodents, the longer human elimination half-
lives were preferred at the ﬁrst modeling attempt (Geyer et al.,
2004). However, model simulations with these half-lives under-
estimated the Black Sea dataset. To solve this, the ﬁsh intake rate
(e.g. PBDE concentration in the prey) or the elimination half-lives had
to be increased.
The ﬁsh intake rate was calculated based on the PBDE concen-
trations in milk of Black Sea porpoises. The difference in PCB 153
concentrations in ﬁsh and milk (116 times; Weijs et al., 2010a) was
used to estimate the ﬁsh PBDE concentrations. Although the validity
of these input concentrations cannot be checked, the calculated
milk:ﬁsh factor of 116 is similar to themilk:ﬁsh ratios of several PCBs
(Weijs et al., 2011) which have comparable tissue/blood partition
coefﬁcients as the PBDEs in the present study (Table 1; Weijs et al.,
2011). Since there was no further available information to calculate
newﬁsh intake concentrations, the only solutionwas thus to increase
the elimination half-lives.
The elimination half-lives were originally lowest, so faster elimi-
nation, for PBDE 100 followed by PBDE 99, 47 and 153, respectively.
The elimination half-lives found by the software after ﬁtting to the
Black Sea datawere lowest for PBDE47, followedby PBDE100, 99 and
153 (Table 1). These ﬁndings are in accordance with the results of
Lupton et al. (2009)who reported that PBDE153wasnotmetabolized
by human liver microsomes, but are in contrast with the same study
which found that the relative rate of PBDE99metabolismwas slightly
faster than that of PBDE 47 in humans. Lupton et al. (2009) investi-
gated only the metabolic biotransformation of PBDEs, whereas the
elimination half-lives in the current models also include fecal and
urinary excretion. According to our results, PBDE 153 is more
persistent than PBDE 47 in marine mammals, although the concen-
trations of PBDE 47 aremuch higher than of PBDE153 due to a higher
input (higher concentrations in prey ﬁsh) caused by a higher solu-
bility and bioavailability of PBDE 47. The differences in behavior of
PBDEs among species (e.g. rodents, humans) and the lack of infor-
mation about elimination of PBDEs in marine mammals complicate
the search for appropriate elimination half-lives. Nevertheless,
within the limits of the PBPK models and the input concentrations
used, the current elimination half-lives are the most viable values.
The elimination half-life in this study includes elimination
through metabolic breakdown and fecal/urinary excretion although
the urinary excretion will be very low due to the high lipophilic
nature of the four PBDEs. As an overall elimination half-life, it is
impossible to distinguish between these three processes in the
models. Nevertheless, with the currently available information, the
Fig. 2. Time trends in age-dependent bioaccumulation of (A) PBDE 47, (B) PBDE 99, (C) PBDE 100 and (D) PBDE 153 in blubber of male harbour porpoises from the North Sea. All
concentrations are expressed in ng/g lw. ¼ individual data for male harbour porpoises from the North Sea from 1990e2001,C¼ individual data for male harbour porpoises from
the North Sea from 2002e2008, ¼model prediction for male harbour porpoises from 1990e2001, ¼model prediction for male harbour porpoises from 2002e2008.
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three processes are not equally important and are highly species-
speciﬁc. Since there were no fecal or urine samples of Black Sea
porpoises available for analysis, it is impossible to estimate the levels
of PBDEs in their feces or urine. Urinary elimination of the parent
PBDE 47, one of the most persistent PBDEs, has been described in
mice as an important elimination pathway (Örn and Klasson-Wehler,
1998; Staskal et al., 2005). However, other studies have shown that
urinaryelimination of PBDEs plays onlyaminor role in rats (Hakk and
Letcher, 2003; Emond et al., 2010). The lack of consistency between
elimination pathways in mice and rats makes the extrapolation to
marine mammals difﬁcult.
PBDEs can be metabolically biotransformed into HO-PBDEs
metabolites, but can also be debrominated into lower brominated
PBDEs or form bromophenols through a cleavage of the ether bridge
(Qiu et al., 2007). Debromination of PBDEs in common solewasmore
important than the formation of HO-PBDEs (Munschy et al., 2010).
This was also conﬁrmed for PBDE 99 for common carp and Chinook
salmon, but the end product of debromination differed among
species (PBDE 47 for common carp and PBDE 49 for Chinook salmon)
(Browne et al., 2009). Contrastingly, human liver cells metabolized
PBDEs in vitro primarily to oxidativemetabolites rather than through
reductive debromination (Lupton et al., 2009; Stapleton et al., 2009).
McKinney et al. (2006) reported insigniﬁcant metabolic biotransfor-
mation of PBDE 47, 99, 100 and 153 in beluga whales, whereas these
compounds were signiﬁcantly depleted by rat microsomes. De Boer
et al. (1998) found no indication for biotransformation of PBDE
47 and 99 in a white beaked dolphin, a sperm whale and a harbour
seal. In addition,Weijs et al. (2009c) showed thatHO-PBDEswere not
detected in serum of harbour porpoises, even though blood is the
preferred storage medium because of their higher afﬁnity for plasma
proteins than for lipids. This suggests that metabolic biotransfor-
mation of PBDEs into HO-PBDEs is probably not an important elim-
ination pathway in marine mammals. Model simulations excluding
elimination processes predicted curves with much steeper upward
slopes which are obviously not consistent with the dataset from the
Black Sea (models not shown). Differences between those models
without elimination half-lives and the current models indicate the
existence of eliminationprocesses inporpoises. However, themodels
are not capable of pointing at a speciﬁc elimination route.
4.1.2. Brain PBDE concentrations in relation to lipid composition
and blood/brain barrier
Similar to the PBPK models for PCBs in porpoises (Weijs et al.,
2011), the blood/brain partition coefﬁcients (PB) calculated with
themethod fromParhamet al. (1997) and the lipid percentages of the
tissues (Weijs et al., 2010a,b) were too high, leading to over-
estimations of the real data (Fig. 1D and Supporting Information
Fig. S1-3D). In vitro studies have shown that the afﬁnity of PCBs for
triglycerides, the major group of lipids in the blubber, is higher than
for phospholipids which are more abundant in the brain
(Sandermann, 2003). Therefore, the lower PBs for PBDEs can be due
to the different lipid composition of the brain compared to all other
tissues. On the other hand, it has also been reported that the blood/
brain barrier (BBB) is capable of blocking molecules larger than
180 Da (Doolittle et al., 1998) from entering the brain. Since the
investigated PBDEs have molecular weights higher than 180 Da
(Burreau et al., 1997), both options can be used to explain the lower
PBs. In the PBPKmodels for PCBs, the PB of PCB 99was comparable to
PCB 180 despite their different molecular sizes indicating a higher
inﬂuence of the lipid composition of the brain (Weijs et al., 2011).
However, the role of the brain lipid composition or the presence of
a BBB on the uptake of PBDEs in the brain is less predictable, as the
PBs are different for each PBDE congener.
PBDE47has a lower PB thanPBDE153, although their partitioning
is similar in other tissues (Table 1). The lower PB of PBDE 47 suggests
that the brain is muchmore efﬁcient in blocking PBDE 47 (molecular
weight: 485, Effective Cross Section (ECS): 8.1 Å) from entering the
brain than PBDE 153 (molecular weight: 646, ECS: 9.6 Å; Burreau
et al., 1997). On the other hand, PCB 153 is also a smaller molecule
than PBDE153 (Burreau et al.,1997), but has the same PB as PBDE153
(Table 1;Weijs et al., 2010a). Therefore, it appears that the brain lipid
composition and not the BBB, is important to explain the distribution
of PBDEs in the brain. Contrastingly, PBDE 99has a lower PB than PCB
99 (Weijs et al., 2011), but the samepartition coefﬁcients for the other
tissues.
The lower concentrations of PBDEs in the brain compared to
blubber or other tissues of porpoises are not uncommon and they
have been reported as well in polar bears (Letcher et al., 2009) and
striped dolphins (Isobe et al., 2009). However, none of these studies
included enough information on the lipid composition of the brain to
present this as an alternative explanation next to the presence of
a BBB.
4.1.3. Assimilation efﬁciency of milk
Levels of PBDEs in harbour porpoise calves depend on the
concentrations of the PBDEs in the milk and on the assimilation
efﬁciencies. The concentrations of the individual PBDEs used in the
present study were the average of 7 milk samples of harbour
porpoise mothers from the Black Sea in 1997e1998. The assimila-
tion efﬁciencies for the uptake of PBDEs through milk in harbour
porpoise calves are not reported in the literature so these param-
eters were ﬁtted in order to achieve good model predictions. The
resulting assimilation efﬁciencies for milk were lower than the
assimilation efﬁciencies for ﬁsh. This can indicate that calves are
somewhat protected against the PBDEs delivered by the milk of
their mothers as they seem to absorb on average only a third of the
PBDEs present in the ingested milk (Table 1). To investigate this
explanation, PBDEs in feces or urine samples of harbour porpoise
calves should be analyzed as the concentrations are expected to be
proportionally much higher than in feces or urine samples of
juvenile or adult harbour porpoises. Unfortunately, samples of feces
and urine were not available for this study in any animal. Never-
theless, even though the calves only absorb a third of the PBDEs
present in the ingested milk, the concentrations in the milk are still
high enough to cause elevated levels in the body of the calves.
4.1.4. Sensitivity analysis
For the sensitivity analysis, the changes in blood curves were
considered. These changes are directly inﬂuenced by the blood
parameters which explain the high sensitivity coefﬁcients found for
parameters like the density of blood and the lipid percentage of
blood. Obviously, the combination of input and output has a large
impact on the bioaccumulation of a chemical in an organism.
However, as mentioned earlier, the calculated ﬁsh concentrations
and ﬁtted elimination half-lives are the best approach available as
the information about both parameters in the literature is non-
existent. The blubber in marine mammals is the main compart-
ment for storage of lipophilic compounds. Anything that can
compromise that, such as the blood/blubber partition coefﬁcient,
has logically consequences for the distribution of the chemical in the
entire body. The concentrations of PBDE 47 in tissues of the fetus are
muchhigher than the concentrations of the other three PBDEs in the
fetus whichmight explainwhy the PBDE 47model is more sensitive
to small changes in dietary milk input than PBDE 99, 100 and 153.
4.2. Goal 2: assessing temporal trends for PBDEs
Concentrations of PBDEs investigated for North Sea porpoises
decreased from 1990 until 2008, but not at the same rate. There was
a 4.2 times difference between levels of PBDE 99 in porpoises in
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1990-2001 and levels of PBDE 99 in animals from 2002e2008
(Fig. 2B). For PBDE 153, there is a 2.5 times difference between the
two time periods (Fig. 2D) followed by a 2.0 and 1.6 times difference
for PBDE 47 and 100, respectively (Fig. 2A, C). The two time periods
were not the same as for PCBs where the groups were divided from
1990e2000 and from 2001e2008 (Weijs et al., 2011). Since the
production of the Penta-BDE mixture containing the investigated
congeners has been banned since 2004, a difference between PBDE
levels in animals from1990e2004 and from2005e2008would seem
plausible. However, harbour porpoises are top predators in the
aquatic food chains and it takes some time to see the result of changes
in the production or release of chemicals throughout the food chain.
The results show that PBDE concentrations were already decreasing
before PBDEswere banned.However, this conclusion shouldbe taken
with caution because it might be that the two groups are divided
differently with larger sample sizes per year. Although there are
reports of increasing PBDE trends in ﬁsh and marine mammals (She
et al., 2002; Lebeuf et al., 2004), there are also studies reporting the
absence of temporal trends (Stapleton et al., 2006) or evendecreasing
trends in guillemot eggs (Sellström et al., 2003) and pike
(Kierkegaard et al., 2004).
Harbour porpoises live for about 20 years and are capable of
producing a calf each year. Because of the high lipid percentage in the
milk, the calves receive high loads of pollutants. In addition, the low
ability for eliminating these compounds in calves, juveniles and
adults ensure that these high loads are retained in the body of the
individual animals and in the population in general. Over 18 years,
PBDE levels have decreased only slowly in harbour porpoises, which
has obviously health implications for the viability of the population.
5. Conclusions
This is the ﬁrst study to assess the kinetics of PBDEs in a marine
mammal species through PBPK modeling. PBPK models combine
physiological information of the species and biochemical infor-
mation of the pollutant and can connect the typical biomonitoring
data with the results of in vitro studies in a non-invasive manner.
The parameterization and validation of the PBPK models were
executed using PBDE data found in the literature from harbour
porpoises from the Black Sea and North Sea. Although some
parameters from other species were proven to be inadequate for
these models, the ﬁnal parameterization was carried out by per-
forming computer optimization using data from Black Sea
porpoises. Since the models with the optimized parameters were
capable of visualizing the slow decrease in PBDE levels in North Sea
porpoises from 1990 until 2008, it proves that the use of these
parameters is justiﬁed for all harbour porpoises. From this
perspective, the PBPKmodels for PBDEs can be used as a framework
to improve our knowledge about the kinetics of PBDEs in harbour
porpoises and to test future exposure scenarios.
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